138 related articles for article (PubMed ID: 12192104)
1. Effect of sildenafil on renin secretion in human subjects.
Chiu YJ; Reid IA
Exp Biol Med (Maywood); 2002 Sep; 227(8):620-5. PubMed ID: 12192104
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
Webb DJ; Freestone S; Allen MJ; Muirhead GJ
Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphodiesterase III with milrinone increases renin secretion in human subjects.
Chiu YJ; Hu SH; Reid IA
J Pharmacol Exp Ther; 1999 Jul; 290(1):16-9. PubMed ID: 10381754
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.
Thiesson HC; Jensen BL; Jespersen B; Schaffalitzky de Muckadell OB; Bistrup C; Walter S; Ottosen PD; Veje A; Skøtt O
Am J Physiol Renal Physiol; 2005 May; 288(5):F1044-52. PubMed ID: 15613622
[TBL] [Abstract][Full Text] [Related]
5. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
Dunkern TR; Hatzelmann A
Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
[TBL] [Abstract][Full Text] [Related]
6. Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue.
Stief CG; Uckert S; Becker AJ; Harringer W; Truss MC; Forssmann WG; Jonas U
Urology; 2000 Jan; 55(1):146-50. PubMed ID: 10654914
[TBL] [Abstract][Full Text] [Related]
7. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro.
Jeremy JY; Ballard SA; Naylor AM; Miller MA; Angelini GD
Br J Urol; 1997 Jun; 79(6):958-63. PubMed ID: 9202566
[TBL] [Abstract][Full Text] [Related]
8. Effects of sildenafil citrate on human hemodynamics.
Jackson G; Benjamin N; Jackson N; Allen MJ
Am J Cardiol; 1999 Mar; 83(5A):13C-20C. PubMed ID: 10078538
[TBL] [Abstract][Full Text] [Related]
9. Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A.
Osinski MT; Rauch BH; Schrör K
Mol Pharmacol; 2001 May; 59(5):1044-50. PubMed ID: 11306686
[TBL] [Abstract][Full Text] [Related]
10. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
[TBL] [Abstract][Full Text] [Related]
11. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
Beierwaltes WH
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
Turko IV; Ballard SA; Francis SH; Corbin JD
Mol Pharmacol; 1999 Jul; 56(1):124-30. PubMed ID: 10385692
[TBL] [Abstract][Full Text] [Related]
13. Does sildenafil indirectly inhibit phosphodiesterase 3 in vascular smooth muscle?
Maurice DH
Hypertension; 2003 Mar; 41(3):e2. PubMed ID: 12623968
[No Abstract] [Full Text] [Related]
14. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase and cGMP-mediated stimulation of renin secretion.
Sayago CM; Beierwaltes WH
Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1146-51. PubMed ID: 11557622
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of cAMP, cGMP and CGRP in sildenafil-induced headache.
Kruuse C; Frandsen E; Schifter S; Thomsen LL; Birk S; Olesen J
Cephalalgia; 2004 Jul; 24(7):547-53. PubMed ID: 15196297
[TBL] [Abstract][Full Text] [Related]
17. PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers.
Kimura M; Higashi Y; Hara K; Noma K; Sasaki S; Nakagawa K; Goto C; Oshima T; Yoshizumi M; Chayama K
Hypertension; 2003 May; 41(5):1106-10. PubMed ID: 12695418
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway.
Andric SA; Janjic MM; Stojkov NJ; Kostic TS
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E544-50. PubMed ID: 20663985
[TBL] [Abstract][Full Text] [Related]
19. Selective phosphodiesterase 5 inhibition does not reduce propofol sedation requirements but affects speed of recovery and plasma cyclic guanosine 3',5'-monophosphate concentrations in healthy volunteers.
Engelhardt T; MacDonald J; Galley HF; Webster NR
Anesth Analg; 2005 Oct; 101(4):1050-1053. PubMed ID: 16192518
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway.
Aboutabl ME; Raafat M; Maklad YA; Kenawy SA; El Din AG
Pharmacol Res; 2008 Jun; 57(6):456-63. PubMed ID: 18572415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]